News Headlines Article

Bayer breaks ground on $100M Berkeley testing facility
San Francisco Business Times

Leaders of drug giant Bayer HealthCare and East Bay political leaders celebrated the company breaking ground Wednesday on a $100 million product testing facility in Berkeley for new hemophilia A treatments. The 80,000-square-foot structure, which the company expects to complete in 2017, will test potential new drugs designed to stop bleeding in patients with the hereditary bleeding disorder, the company said earlier this month.